<DOC>
	<DOCNO>NCT00446771</DOCNO>
	<brief_summary>The study open-label , randomize , crossover design , subject receive mannitol powder inhalation use dry powder inhaler without premedication bronchodilator , mannitol powder inhalation capsule administer orally , mannitol commercial formulation design intravenous use .</brief_summary>
	<brief_title>A Pharmacokinetic Bioavailability Study Mannitol Inhalation Using Normal Subjects</brief_title>
	<detailed_description />
	<mesh_term>Mannitol</mesh_term>
	<criteria>Subject sign write informed consent form . Subject normal male volunteer 18 65 year age . Subject willing comply procedure study remain clinical unit schedule visit . Subject willing abstain chew gum duration study . Subject asthma disease affect lung airway . Subject history indicate possible airway hyperresponsiveness . Subject allergic mannitol gelatin know intolerance intravenous mannitol . Subject us inhale drug ( legal illegal ) . Subject use oral bronchodilator drug . Subject celiac disease , Crohn 's disease disease affect intestinal absorption . Subject renal impairment condition would affect urine collection . Subject 's weight deviate 15 % ideal weight list height Metropolitan Life table . Subject smoker . Subject participate another clinical trial within past 30 day . Subject use chew gum within past 72 hour . Subject need use bisphosphonates , nonsteroidal antiinflammatory agent , drug know affect intestinal permeability chronic basis . Subject use nonsteroidal antiinflammatory agent within past 72 hour</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
</DOC>